期刊文献+

双去甲氧基姜黄素抑制肝癌细胞增殖并诱导凋亡的机制 被引量:3

Mechanism of bisdemethoxycurcumin inhabits proliferation of hepatocellular carcinoma cell and induces apoptosis
下载PDF
导出
摘要 目的探讨双去甲氧基姜黄素(BDMC)对肝癌细胞的作用及其机制。方法不同BDMC(0、20、40、80μmol/L)干预肝癌细胞株HEPG2 72 h,MTT评价细胞增殖,Tunel分析细胞凋亡,ELISA检测活性氧(ROS)水平和p-STAT3水平,Western blot检测AMPK。采用ROS抑制剂N-乙酰-L半胱氨酸(NAC 2.5 mmol/L)处理30 min后BDMC再干预24 h,评价细胞凋亡能力。结果 BDMC可诱导肝癌细胞凋亡,增加ROS生成和AMPK磷酸化水平,抑制p-STAT3表达。抑制ROS生成可抑制BDMC诱导HEPG2凋亡的能力。结论 BDMC通过ROS/AMPK/STAT3信号通路诱导肝癌细胞凋亡。 Objective To investigate the effect and mechanism of bisdemethoxycurcumin (BDMC) on hepatocellular carcinoma cells. Methods Hepatoma cell line HEPG2 cells were treated with different concentrations of BDMC (0, 20, 40, 80 wmol/L) for 72 h, and then the cell prolifera- tion was measured by MTF. Cell apoptosis was evaluated by TUNEL analysis. ELISA was used to de- tect the level of intracellular reactive oxygen species (ROS) and STAT3 phosphorylation ( p-STAT3 ), and Western blot was used to detect the expression of AMPK. Processed by ROS inhibitor N- acetyl -L cysteine (2.5 mmol/L NAC) for 30 min, cells were treated with BDMC for 24 h, and the ability of cell apoptosis was evaluated. Results BDMC was able to induce apoptosis of hepatocellular carcino- ma cells, increase the intracellular ROS production and AMPK phosphorylation levels, and inhibit the expression of p-STAT3 protein. Inhibition of ROS formation could effectively inhibit the ability of BD- MC in inducing apoptosis of HEPG2 cells. Conclusion BDMC induces apoptosis in hepatocellular carcinoma cells by ROS/AMPK/STAT3 signaling pathway.
机构地区 南通大学医学院
出处 《实用临床医药杂志》 CAS 2016年第15期43-46,共4页 Journal of Clinical Medicine in Practice
基金 江苏省无锡市科技局科技支撑计划(CSE31N1311)
关键词 双去甲氧基姜黄素 肝癌 增殖 凋亡 bisdemethoxycurcumin hepatocellular carcinoma proliferation apoptosis
  • 相关文献

参考文献12

  • 1谢玉宏.中晚期原发性肝癌介入治疗的疗效及预后[J].实用临床医药杂志,2014,18(3):93-94. 被引量:10
  • 2郭兴军,郑艳红,关强,王星.肝动脉化疗栓塞联合射频消融术治疗原发性肝癌的疗效分析[J].实用临床医药杂志,2015,19(5):44-47. 被引量:19
  • 3蔡颖,宋珅,徐杰,陈建伟,崔小兵.不同来源莪术中姜黄素类成分的含量差异研究[J].药学与临床研究,2014,22(6):502-505. 被引量:3
  • 4何太平,莫丽儿,梁念慈.3种姜黄素类似物对重组人促肝细胞再生磷酸酶-3活性的影响[J].时珍国医国药,2011,22(5):1164-1166. 被引量:1
  • 5Yu C C, Yang M D, Lin H Y, et al. Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells [J]. In Vivo, 2015, 29(6) : 711 - 728.
  • 6Xu J, Yang H, Zhou X, et al. Bisdemethoxyeurcumin sup- presses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expres- sion, and inducing autophagy [J]. Mol Med Rep, 2015, 12 (5) : 7603 - 7608.
  • 7Song W, Qiao X, Liang W F, et al. Efficient separation of curcumin, demethoxycurcumin, and bisdemethoxycurcumin from turmeric using supercritical fluid chromatography: From analytical to preparative scale[J].J Sep Sci, 2015, 38 (19) : 3450 - 3453.
  • 8Luo C, DU Z, Wei X, et al. Bisdemethoxycurcumin attenu- ates gastric adenocarcinoma growth by inducing mitochondrial dysfunction [ J]. Oncol Lett, 2015, 9 (1) : 270 -274.
  • 9Li Y B, Gao J L, Zhong Z F, et al. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accu- mulation and modulating senescence-related pathways [ J ]. Pharmacol Rep, 2013, 65(3) : 700 -709.
  • 10Nerstedt A, Johansson A, Andersson C X, et al. AMP-acti- vated protein kinase inhibits IL-6-stimulated inflammatory re- sponse in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3) [ J ]. Diabetologia, 2010, 53 ( 11 ) : 2406 - 2416.

二级参考文献39

  • 1SHEN Xing-gui,SUN Li-wen,JIAO Ming,LI Zhao-fa,ZHAO Zhi-zhuang,LI Qing-shan,FU Xue-qi,HUANG Zhong-xiu.Kinetics of Phosphatase of Regenerating Liver-3(PRL-3) Inhibition by Small-molecular Inhibitors[J].Chemical Research in Chinese Universities,2006,22(2):221-224. 被引量:2
  • 2何媛媛,于得才,孔令辉,李红英.姜黄超临界CO_2流体萃取物姜黄素含量测定[J].中成药,2007,29(1):122-124. 被引量:1
  • 3成晓静,刘华钢,赖茂祥.莪术的化学成分及药理作用研究概况[J].广西中医学院学报,2007,10(1):79-82. 被引量:45
  • 4国家药典委员会.中华人民共和国药典第一部[S].北京:化学工业出版社,2005:142.
  • 5E[Serag HB, Rudolph KL. Hepatoeellular carcinom: epidemiology and molecular cacinogenesis [J].Gastroenterology, 2007, 132 (7): 2557-2576.
  • 6Beerenwinke L, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer [J]. PLoS Comput Biol, 2007, 3 (11): e225.
  • 7Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: A systematic review [J]. CurrGenomics, 2011, 12 (2): 130-137.
  • 8Justin C, Ben HP. Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy [J]. J Mammary Gland Biol, 2012, 17 (3): 205-216.
  • 9Treiber G. roTOR inhibitors for hepatocellular cancer: a forward-moving target [J]. Expert Rev Anticancer Ther, 2009, 9 (2): 247-261.
  • 10SeitaJ, Asakawa M, Ooehara J, et al. Interleukin-27 directly induces differentiation in bematopoietic stem cells [J]. Blood, 2008, 111 (4): 1903-1912.

共引文献31

同被引文献39

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部